{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"autosomal-dominant-hyperinsulinism-due-to-kir6-2-deficiency","columns":[{"gene":"","key":"population-e8997c08c8116a16ec1b","label":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","mondoId":"MONDO:0017185","onsetQualifier":null,"originColumnKey":"MONDO:0017185/ORPHA:276580","originalViews":[{"key":"MONDO:0017185/ORPHA:276580","label":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","scopeLabel":"ORPHA:276580","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["06cc1babdadc3effda19341cd4c32cf16090d838be7a2eba8e2b87bc70eeaa01","0b1e80fe89a6e5bee172c447fa5009c5dbace6fa0a862ca49bc9bc0abfe0c47e","0c8346e36912b0ab43a597bc28a64a649c0a9fd5d5b9e1233d1eb433fc80b55d","144f809e2e7787345f8e058ceeab87efc602b9390a7636318c1fcc5668655ca5","22b121fa01f049ff46461656a703a5c4bb26e17fbc570b1fbc18fd6de7b94ea8","2f017cff682b49bf50a2db09ac2a2998e7dfd77a35c5f44159506881f274800e","426af12405b17c11e900f7a77af2b8983fcbd78bf7c91fd5d19384bed0be6ce7","4ede961a6bc1649fda8fa26b637bca3d48f5deb37ca434598cf02de25b0c873d","58c75cd1b47b38257744c50f517c19a836e381dd8538e538a115b6d6e612712c","5e1ce1a40cbdf097197ff9e87c859b6be4792f7a4db7929c11b34b9465211741","6117fd8f40dc3b2eed516a85b2dc4b27439b71fb0e26eaaf0c2be5b170e4ec0a","630d624c4a3e5d1ebeda6b50c2439c6b7fca041a56b51b6b4191a8fe38f1da60","8861cc993756b2fe667a32986c9fcd284b83438816b17d04938ec1c8aa847c06","973b8600116a49c69085350618ca2f172f7dd3ef31d634e2151f0a57dda76fb0","9993bbabea2285f376dc180a5f3c5534d7536f34edafa8e2a0b35c0de4c1ea8f","9e036f1921deed282d001751803eeb377c6812c00036403f6abf8afcde9b3722","a3a8fa81ca58377b4888d30dd10ec4f5d22a10e97023f54f2d97149fd3edc7c7","ade8e623f2d2d46104d71eee0bf184f4eccac30316bb149a17ff378a23bd18d7","c5d31d86745ba48c4fcfb9f01d5898437be0863a9e7dad08b0f2ce69d1344b4c","ca6c7d1ed82458438eb973d6bdc7e2793640ff3656ea3e433bb3f45991183781","d21ab302b77983a838b7ca9be931130894c05b7317798bde3c0ce03106e49c7d","d81be3828623bbf9d8eaad327d21a81a21488abbffc33436266509e5198a4bd8","d8d31b817110701ba3bb38adc7b6f8a7f7355f4d9399e6eb97b4af8b118b24b6","dc1f36e80a26bd0f41b58c2bceb72edcbe840117dfb329a1b815a20d37cd718a","eb7dd657cac5ef0b8fc1f9d64103d93adb43bcedeb6dc0cb0a861c1d02d23460","f03cbeb7dce64033e9f76b9ad71fb13262666c52c9e21d559451cffc7c3af22b","f1c7bf5c1c6de73c44109009b22a9693a1381504656a3fdf434c639434479d56","ff63a8f02629228fa188498c2a52608b319668b93e903f97810c1e7365656487"],"recordQualifiers":{},"scopeLabel":"ORPHA:276580","sourceIds":["ORPHA:276580"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-e8997c08c8116a16ec1b"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0004924","HP:0000713","HP:0031224","HP:0002329","HP:0030796","HP:0001069","HP:0031084"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":28,"sourceGroups":{"orphanet":28}},"features":[{"hpoId":"HP:0004924","label":"Abnormal oral glucose tolerance","primary":true},{"hpoId":"HP:0000713","label":"Agitation","primary":true},{"hpoId":"HP:0031224","label":"Diffuse pancreatic islet hyperplasia","primary":true},{"hpoId":"HP:0002329","label":"Drowsiness","primary":true},{"hpoId":"HP:0030796","label":"Elevated circulating C-peptide concentration","primary":true},{"hpoId":"HP:0001069","label":"Episodic hyperhidrosis","primary":true},{"hpoId":"HP:0031084","label":"Excessive insulin response to glucagon test","primary":true},{"hpoId":"HP:0003162","label":"Fasting hypoglycemia","primary":false},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0000842","label":"Hyperinsulinemia","primary":false},{"hpoId":"HP:0000825","label":"Hyperinsulinemic hypoglycemia","primary":false},{"hpoId":"HP:0001639","label":"Hypertrophic cardiomyopathy","primary":false},{"hpoId":"HP:0001325","label":"Hypoglycemic coma","primary":false},{"hpoId":"HP:0002173","label":"Hypoglycemic seizures","primary":false},{"hpoId":"HP:0001985","label":"Hypoketotic hypoglycemia","primary":false},{"hpoId":"HP:0001520","label":"Large for gestational age","primary":false},{"hpoId":"HP:0001254","label":"Lethargy","primary":false},{"hpoId":"HP:0007185","label":"Loss of consciousness","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0012759","label":"Neurodevelopmental abnormality","primary":false},{"hpoId":"HP:0000980","label":"Pallor","primary":false},{"hpoId":"HP:0001962","label":"Palpitations","primary":false},{"hpoId":"HP:0002591","label":"Polyphagia","primary":false},{"hpoId":"HP:0002133","label":"Status epilepticus","primary":false},{"hpoId":"HP:0001279","label":"Syncope","primary":false},{"hpoId":"HP:0001649","label":"Tachycardia","primary":false},{"hpoId":"HP:0100651","label":"Type I diabetes mellitus","primary":false}],"ledeHtml":"A form of diazoxide-sensitive diffuse hyperinsulinism (DHI) characterized by hypoglycemic episodes that are usually mild, escaping detection during infancy. Autosomal dominant hyperinsulinism due to Kir6.2 deficiency usually has a milder phenotype when compared to that resulting from recessive K+ (K-ATP) channel mutations (Recessive forms of diazoxide-resistant hyperinsulinism).","mondoId":"MONDO:0017185","node":{"canonicalSlug":"autosomal-dominant-hyperinsulinism-due-to-kir6-2-deficiency","comparisons":[{"documentSha256":"694c1a6d64dc5380af3aeb2b7a6f4cd02838442544e7be9faa4339e1e2b1ece2","key":"legacy-hyperinsulinemic-hypoglycemia","kind":"legacy","label":"hyperinsulinemic hypoglycemia","memberIds":["MONDO:0005803","MONDO:0009734","MONDO:0011153","MONDO:0011236","MONDO:0011717","MONDO:0012381","MONDO:0012382","MONDO:0012396","MONDO:0016988","MONDO:0017183","MONDO:0017184","MONDO:0017185","MONDO:0017189","MONDO:0017935","MONDO:0018465","MONDO:0019334","MONDO:0859362"],"mondoId":"MONDO:0005803","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hyperinsulinemic-hypoglycemia.694c1a6d64dc5380af3aeb2b7a6f4cd02838442544e7be9faa4339e1e2b1ece2.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","originalSourceId":"ORPHA:276580","paragraphs":["A form of diazoxide-sensitive diffuse hyperinsulinism (DHI) characterized by hypoglycemic episodes that are usually mild, escaping detection during infancy. Autosomal dominant hyperinsulinism due to Kir6.2 deficiency usually has a milder phenotype when compared to that resulting from recessive K+ (K-ATP) channel mutations (Recessive forms of diazoxide-resistant hyperinsulinism)."],"rawAttribution":"MONDO:0017185","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:19Z","upstream":"ORPHA:276580","url":"https://rarediseases.info.nih.gov/diseases/17284"},"ownColumnKeys":["population-e8997c08c8116a16ec1b"],"publication":"published","relationships":[{"kind":"parent","label":"hyperinsulinemic hypoglycemia, familial, 2","mondoId":"MONDO:0011153","slug":"hyperinsulinemic-hypoglycemia-familial-2"},{"kind":"parent","label":"diazoxide-sensitive diffuse hyperinsulinism","mondoId":"MONDO:0015624","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"range","key":"06cc1babdadc3effda19341cd4c32cf16090d838be7a2eba8e2b87bc70eeaa01","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002133","is_excluded":false,"label":"Status epilepticus","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0b1e80fe89a6e5bee172c447fa5009c5dbace6fa0a862ca49bc9bc0abfe0c47e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002591","is_excluded":false,"label":"Polyphagia","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0c8346e36912b0ab43a597bc28a64a649c0a9fd5d5b9e1233d1eb433fc80b55d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007185","is_excluded":false,"label":"Loss of consciousness","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"144f809e2e7787345f8e058ceeab87efc602b9390a7636318c1fcc5668655ca5","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031224","is_excluded":false,"label":"Diffuse pancreatic islet hyperplasia","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"22b121fa01f049ff46461656a703a5c4bb26e17fbc570b1fbc18fd6de7b94ea8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001254","is_excluded":false,"label":"Lethargy","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2f017cff682b49bf50a2db09ac2a2998e7dfd77a35c5f44159506881f274800e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002329","is_excluded":false,"label":"Drowsiness","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"426af12405b17c11e900f7a77af2b8983fcbd78bf7c91fd5d19384bed0be6ce7","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001649","is_excluded":false,"label":"Tachycardia","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4ede961a6bc1649fda8fa26b637bca3d48f5deb37ca434598cf02de25b0c873d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0100651","is_excluded":false,"label":"Type I diabetes mellitus","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"58c75cd1b47b38257744c50f517c19a836e381dd8538e538a115b6d6e612712c","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001962","is_excluded":false,"label":"Palpitations","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5e1ce1a40cbdf097197ff9e87c859b6be4792f7a4db7929c11b34b9465211741","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000713","is_excluded":false,"label":"Agitation","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6117fd8f40dc3b2eed516a85b2dc4b27439b71fb0e26eaaf0c2be5b170e4ec0a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012759","is_excluded":false,"label":"Neurodevelopmental abnormality","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"630d624c4a3e5d1ebeda6b50c2439c6b7fca041a56b51b6b4191a8fe38f1da60","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8861cc993756b2fe667a32986c9fcd284b83438816b17d04938ec1c8aa847c06","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003162","is_excluded":false,"label":"Fasting hypoglycemia","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"973b8600116a49c69085350618ca2f172f7dd3ef31d634e2151f0a57dda76fb0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001325","is_excluded":false,"label":"Hypoglycemic coma","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9993bbabea2285f376dc180a5f3c5534d7536f34edafa8e2a0b35c0de4c1ea8f","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001279","is_excluded":false,"label":"Syncope","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9e036f1921deed282d001751803eeb377c6812c00036403f6abf8afcde9b3722","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000825","is_excluded":false,"label":"Hyperinsulinemic hypoglycemia","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a3a8fa81ca58377b4888d30dd10ec4f5d22a10e97023f54f2d97149fd3edc7c7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001985","is_excluded":false,"label":"Hypoketotic hypoglycemia","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ade8e623f2d2d46104d71eee0bf184f4eccac30316bb149a17ff378a23bd18d7","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000980","is_excluded":false,"label":"Pallor","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c5d31d86745ba48c4fcfb9f01d5898437be0863a9e7dad08b0f2ce69d1344b4c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004924","is_excluded":false,"label":"Abnormal oral glucose tolerance","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ca6c7d1ed82458438eb973d6bdc7e2793640ff3656ea3e433bb3f45991183781","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d21ab302b77983a838b7ca9be931130894c05b7317798bde3c0ce03106e49c7d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0031084","is_excluded":false,"label":"Excessive insulin response to glucagon test","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d81be3828623bbf9d8eaad327d21a81a21488abbffc33436266509e5198a4bd8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030796","is_excluded":false,"label":"Elevated circulating C-peptide concentration","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d8d31b817110701ba3bb38adc7b6f8a7f7355f4d9399e6eb97b4af8b118b24b6","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001069","is_excluded":false,"label":"Episodic hyperhidrosis","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dc1f36e80a26bd0f41b58c2bceb72edcbe840117dfb329a1b815a20d37cd718a","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"eb7dd657cac5ef0b8fc1f9d64103d93adb43bcedeb6dc0cb0a861c1d02d23460","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001520","is_excluded":false,"label":"Large for gestational age","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f03cbeb7dce64033e9f76b9ad71fb13262666c52c9e21d559451cffc7c3af22b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002173","is_excluded":false,"label":"Hypoglycemic seizures","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f1c7bf5c1c6de73c44109009b22a9693a1381504656a3fdf434c639434479d56","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001639","is_excluded":false,"label":"Hypertrophic cardiomyopathy","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ff63a8f02629228fa188498c2a52608b319668b93e903f97810c1e7365656487","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276580","disease_name":"Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000842","is_excluded":false,"label":"Hyperinsulinemia","onset_id":null,"reference":"ORPHA:276580","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17284\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017185\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:276580</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A form of diazoxide-sensitive diffuse hyperinsulinism (DHI) characterized by hypoglycemic episodes that are usually mild, escaping detection during infancy. Autosomal dominant hyperinsulinism due to Kir6.2 deficiency usually has a milder phenotype when compared to that resulting from recessive K+ (K-ATP) channel mutations (Recessive forms of diazoxide-resistant hyperinsulinism).</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17284\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"autosomal-dominant-hyperinsulinism-due-to-kir6-2-deficiency","sourceDocuments":[{"name":"GARD: Autosomal dominant hyperinsulinism due to Kir6.2 deficiency","reviewed":null,"source_release":"2026-10-25T03:42:19Z","url":"https://rarediseases.info.nih.gov/diseases/17284"},{"name":"MONDO: autosomal dominant hyperinsulinism due to Kir6.2 deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0017185"}],"sourceNote":"","synonyms":["autosomal dominant hyperinsulinemic hypoglycemia due to Kir6.2 deficiency","dominant KATP hyperinsulinism due to Kir6.2 deficiency"],"takeawayHtml":"","title":"autosomal dominant hyperinsulinism due to Kir6.2 deficiency"},"schemaVersion":1}
